Skip to content
ADAPTILENS ANNOUNCES $17.5M SERIES A FINANCING
  • Home
  • Our Technology
  • Team
  • News
  • Contact
Menu
  • Home
  • Our Technology
  • Team
  • News
  • Contact

Day: July 26, 2022

Dr. Clamen featured in the Amazing Execs episode 102 “Developing a Breakthrough New Ophthalmic Medical Device”

In Episode #102 of the Amazing Execs Show, Dr. Liane Clamen, CEO and founder of Adaptilens, discusses her journey in developing an accommodating intraocular lens designed to restore the eye’s natural focusing ability for cataract patients. She shares insights into the challenges of medical device startups, the importance of assembling a skilled and passionate team, […]

Adaptilens is made possible with help from​
notice: The Adaptilens is in the development phase and is not yet approved for investigational or commercial use.

Follow our progress on

Linkedin